Peregrine announces new AML STCs for the Aviation Clean Air (ACA) system, covering the Challenger Series 600, Dassault Falcon models and the Gulfstream G-IV family, as well as smaller, single ECS duct, aircraft including Learjet Models 35,
Peregrine announces new AML STCs for the Aviation Clean Air (ACA) system, covering the Challenger Series 600, Dassault Falcon models and the Gulfstream G-IV family, as well as smaller, single ECS duct, aircraft including Learjet Models 35,
Peregrine, Peak Medevac International and Haggan Aviation partnered for STC installations of the Aviation Clean Air (ACA) ionic air cleaning system in medevac aircraft. This system, part of a multi-layered disinfection program utilizes ionic air cleansing to
Peregrine Avionics has obtained a Approved Model List Supplemental Type Certificate (AML STC) forthe installation of the ACA Needle Point Bipolar Ionization (NPBI™) system in Gulfstream G-IV,Challenger 600 Series and Dassault Falcon 50 and 900 aircraft models.
Peregrine-developed Supplemental Type Certificate (STC) and Approved Model List (AML) for the installation of Aviation Clean Air (ACA) active pathogen disinfection technology, including neutralization of the COVID-19 virus, is now available for Bombardier Challenger Series 600 aircraft,
Peregrine has been selected as the exclusive source for the Challenger 600 family of aircraft for the Aviation Clean Air (ACA) active pathogen disinfection technology, including the neutralization of the COVID-19 virus. The STC is available from
The dramatic negative impact to the aviation industry from the on-going COVID-19 pandemic is unprecedented. In response, Peregrine developed multiple STCs for non-chemical mitigation and neutralizing of surface and airborne pathogens in aircraft. Please have a look
Peregrine has some exciting news in the area of protecting aircraft interiors from COVID-19 propagation. Peregrine and Lee Aerospace announce the Aviation Clean Air (ACA) system Supplemental Type Certificate (STCs) for the Citation 560XL to address COVID-19.